Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 6, 2010, Pages

  Ueta, Mayumi ^a,b   Sotozono, Chie ^a   Nakano, Masakazu ^a   Taniguchi, Takazumi ^a   Yagi, Tomohito ^a   Tokuda, Yuichi ^a   Fuwa, Masahiro ^a   Inatomi, Tsutomu ^a   Yokoi, Norihiko ^a   Tashiro, Kei ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

genome wide association study; Prostaglandin E receptor 3; single nucleotide polymorphism; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 78649261313     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.08.007     Document Type: Article

References (40)

1. R. Forman, G. Koren, and N.H. Shear Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A review of 10 years' experience Drug Saf 25 2002 965 972
2. C. Leaute-Labreze, T. Lamireau, D. Chawki, J. Maleville, and A. Taieb Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome Arch Dis Child 83 2000 347 352
3. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600 1607
4. C. Sotozono, M. Ueta, N. Koizumi, T. Inatomi, Y. Shirakata, and Z. Ikezawa Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications Ophthalmology 116 2009 685 690
5. M. Ueta Innate immunity of the ocular surface and ocular surface inflammatory disorders Cornea 27 suppl 2008 S31 S40
6. M. Ueta, and S. Kinoshita Innate immunity of the ocular surface Brain Res Bull 81 2010 219 228
7. M. Ueta, C. Sotozono, T. Inatomi, K. Kojima, K. Tashiro, and J. Hamuro Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome Br J Ophthalmol 91 2007 962 965
8. J.Z. Yetiv, J.R. Bianchine, and J.A. Owen Jr. Etiologic factors of the Stevens-Johnson syndrome South Med J 73 1980 599 602
9. S. Halevy, P.D. Ghislain, M. Mockenhaupt, J.P. Fagot, J.N. Bouwes Bavinck, and A. Sidoroff Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel J Am Acad Dermatol 58 2008 25 32
10. N. Levi, S. Bastuji-Garin, M. Mockenhaupt, J.C. Roujeau, A. Flahault, and J.P. Kelly Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis Pediatrics 123 2009 e297 e304
11. W.J. Power, M. Ghoraishi, J. Merayo-Lloves, R.A. Neves, and C.S. Foster Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum Ophthalmology 102 1995 1669 1676
12. R. Wolf, E. Orion, B. Marcos, and H. Matz Life-threatening acute adverse cutaneous drug reactions Clin Dermatol 23 2005 171 181
13. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, and H.C. Ho Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
14. T. Dainichi, H. Uchi, Y. Moroi, and M. Furue Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity? Dermatology 215 2007 86 88
15. B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol Proc Natl Acad Sci U S A 102 2005 4134 4139
16. C. Lonjou, N. Borot, P. Sekula, N. Ledger, L. Thomas, and S. Halevy A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs Pharmacogenet Genomics 18 2008 99 107
17. C. Lonjou, L. Thomas, N. Borot, N. Ledger, C. de Toma, and H. LeLouet A marker for Stevens-Johnson syndrome.: ethnicity matters Pharmacogenomics J 6 2006 265 268
18. B.J. Mondino, S.I. Brown, and A.W. Biglan HLA antigens in Stevens-Johnson syndrome with ocular involvement Arch Ophthalmol 100 1982 1453 1454
19. W.J. Power, S.L. Saidman, D.S. Zhang, E.C. Vamvakas, J.M. Merayo-Lloves, and A.H. Kaufman HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome Ophthalmology 103 1996 1406 1409
20. J.C. Roujeau, C. Bracq, N.T. Huyn, E. Chaussalet, C. Raffin, and N. Duedari HLA phenotypes and bullous cutaneous reactions to drugs Tissue Antigens 28 1986 251 254
21. J.C. Roujeau, T.N. Huynh, C. Bracq, J.C. Guillaume, J. Revuz, and R. Touraine Genetic susceptibility to toxic epidermal necrolysis Arch Dermatol 123 1987 1171 1173 (Pubitemid 17119310)
22. Y. Araki, C. Sotozono, T. Inatomi, M. Ueta, N. Yokoi, and E. Ueda Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset Am J Ophthalmol 147 2009 1004 1011 e1
23. C. Sotozono, L.P. Ang, N. Koizumi, H. Higashihara, M. Ueta, and T. Inatomi New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome Ophthalmology 114 2007 1294 1302
24. M. Ueta, C. Sotozono, T. Inatomi, K. Kojima, J. Hamuro, and S. Kinoshita Association of IL4R polymorphisms with Stevens-Johnson syndrome J Allergy Clin Immunol 120 2007 1457 1459
25. M. Ueta, C. Sotozono, T. Inatomi, K. Kojima, J. Hamuro, and S. Kinoshita Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications Invest Ophthalmol Vis Sci 49 2008 1809 1813
26. M. Ueta, C. Sotozono, T. Inatomi, K. Kojima, J. Hamuro, and S. Kinoshita Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome Br J Ophthalmol 92 2008 989 991
27. A0206 and Stevens-Johnson syndrome in the Japanese Am J Ophthalmol 143 2007 367 368 (Pubitemid 46136149)
28. M. Ueta, K. Tokunaga, C. Sotozono, T. Inatomi, T. Yabe, and M. Matsushita HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese Mol Vis 14 2008 550 555
29. M. Nakano, Y. Ikeda, T. Taniguchi, T. Yagi, M. Fuwa, and N. Omi Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population Proc Natl Acad Sci U S A 106 2009 12838 12842
30. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, and J.C. Roujeau Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study Arch Dermatol 138 2002 1019 1024
31. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, and J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92 96
32. Y. Yamane, M. Aihara, and Z. Ikezawa Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006 Allergol Int 56 2007 419 425
33. K. Kojima, M. Ueta, J. Hamuro, Y. Hozono, S. Kawasaki, and N. Yokoi Human conjunctival epithelial cells express functional Toll-like receptor 5 Br J Ophthalmol 92 2008 411 416
34. M. Ueta, J. Hamuro, H. Kiyono, and S. Kinoshita Triggering of TLR3 by polyI: C in human corneal epithelial cells to induce inflammatory cytokines Biochem Biophys Res Commun 331 2005 285 294
35. M. Ueta, T. Matsuoka, S. Narumiya, and S. Kinoshita Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis J Allergy Clin Immunol 123 2009 466 471
36. T. Matsuoka, and S. Narumiya Prostaglandin receptor signaling in disease Sci World J 7 2007 1329 1347
37. S. Narumiya Prostanoids and inflammation: a new concept arising from receptor knockout mice J Mol Med 87 2009 1015 1022
38. T. Honda, T. Matsuoka, M. Ueta, K. Kabashima, Y. Miyachi, and S. Narumiya Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity J Allergy Clin Immunol 124 2009 809 818 e2
39. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1999 1193 1226
40. Y. Yamaguchi-Kabata, K. Nakazono, A. Takahashi, S. Saito, N. Hosono, and M. Kubo Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies Am J Hum Genet 83 2008 445 456